Respiratory Medicine and Research

Papers
(The TQCC of Respiratory Medicine and Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial board10
French guidelines for the treatment of cancer-associated venous thromboembolism - 2023 update10
BAP-1 in the diagnosis of malignant pleural mesothelioma9
Epidemiology of interstitial lung diseases in a native Afro-Caribbean population of French West Indies9
Evaluating the correspondence between the EQ-5D-5L and disease severity and quality of life in adults and adolescents with cystic fibrosis9
Different pathways to lung cancer diagnosis in a real-life setting9
Long-term survival comparison between the first and second waves among 265 critical COVID-19 patients admitted to the ICU: A retrospective cohort study8
An underrecognized phenotype of pulmonary emphysema with marked pulmonary gas exchange but with mild or moderate airway obstruction8
Letter to Hitomi Tomohara-Ichishima et al8
Impact of Remdesivir on long-term outcomes in lung transplant recipients with SARS-CoV-2 infection: a retrospective cohort analysis8
Anti-synthetase syndrome: A focus on interstitial lung disease as a diagnostic criteria8
Pulmonary rehabilitation in COPD with suspected pulmonary hypertension: a step toward8
The pandemic effect: The outlook of lung transplantation7
Impact of pulmonary hypertension on lung cancer management7
Use of complementary medicines and self-medication practices in cystic fibrosis – MUCAUTOMED study7
Sarcoidosis-like disease probably induced by apremilast: A case report6
Lung ultrasound and community-acquired pneumonia: from complementary tool to clinical game-changer6
Trends in annual prevalence and incidence of pharmacologically treated idiopathic pulmonary fibrosis in Greece (2019–2023): A nationwide e-prescription study6
Prognostic value of metabolic activity in noncancerous lung areas for stage I lung cancer6
Diaphragm dysfunction evaluated by electroneuromyography in patients with interstitial lung disease (ILD), risks factors and impact on mortality: a retrospective observational study6
Endobronchial valve (EBV) insertion for severe emphysema does not improve skeletal muscle mass or function: A pilot study on 19 patients6
Immunoglobulins as a treatment modality for corticosteroid-refractory pemetrexed-induced interstitial lung disease, case report5
Association of forced oscillation technique measurements with respiratory system compliance and resistance in a 2-compartment physical model5
Psychiatric disorders and long COVID5
Endobronchial ultrasound-guided transbronchial needle injection of cisplatin results in dynamic changes in the tumor immune microenvironment5
Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort5
Molecular profiling of patients with advanced lung adenocarcinoma diagnosed between 2015 and 2020 in French Polynesia5
Organising pneumonia following amivantamab treatment: a case report4
Pulmonary arterial stiffness as the main correlate of effective arterial elastance in pre- and post-capillary pulmonary hypertension4
Pulmonary Arterial Hypertension-approved drugs in Pulmonary Hypertension associated with COPD: A systematic literature review4
Pulmonary ultrasound versus chest radiography in the diagnosis of community-acquired pneumonia in adults: an updated systematic review and meta-analysis4
Pulmonary adverse events of breast silicone implants and silicone injection4
18F-FDG uptake by respiratory muscles in acute respiratory insufficiency in a patient with graft versus host disease4
Feasibility of an innovative follow-up method alternating face-to-face consultations and teleconsultations for adult patients with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor 4
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease4
Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa3
Education and implementation of home spirometry in an adolescent cystic fibrosis population3
Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patients3
Comparison of amikacin lung delivery between AKITA® and eFlow rapid® nebulizers in healthy controls and patients with CF: A randomized cross-over trial3
Update of guidelines for management of Community Acquired pneumonia in adults by the French Infectious Disease Society (SPILF) and the French-Speaking Society of Respiratory Diseases (SPLF)3
Assessment of the interobserver reliability in discharge decision-making for patients undergoing thoracic surgery based on chest ultrasound compared to chest X-ray findings3
Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis3
Pulmonary arterial hypertension and COVID-19: Piecing the puzzle3
Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with ext3
Peripheral cellular biomarkers in bronchiectasis3
Evolving paradigms in pulmonary hypertension: Highlights of the 6th French Pulmonary Hypertension Network Meeting3
Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer3
Understanding participation challenges in lung cancer screening program: Findings from the DEP’KP80 trial in France3
Comparative study of the two diagnostic criteria for idiopathic pleuroparenchymal fibroelastosis3
Exercise testing and counselling within the cystic fibrosis centres in France: A national survey3
Hemodynamic characteristics in patients with pulmonary hypertension and chronic obstructive pulmonary disease: A retrospective monocentric cohort study3
Editorial board2
SPLF/SMFU/SRLF/SFAR/SFCTCV Guidelines for the management of patients with primary spontaneous pneumothorax2
Awake prone position in patients with acute hypoxic respiratory failure: A narrative review2
Fungal colonization and infections in patients with COVID-19 in intensive care units: A real-life experience at a tertiary-care hospital2
Real-world outcomes of patients treated with ≥17 cycles of pembrolizumab monotherapy as first-line therapy and for previously treated advanced NSCLC: multicenter observational study in France2
A 52-year-old immunocompromised man with an unusual cause of infectious lung cavitary inducing acute respiratory failure2
Reply to Gille and collaborators: DM and VC impairment after COVID-12
Burden of unexplained dyspnea: a single-center study2
Impact of preexisting interstitial lung disease on outcomes of lung cancer surgery: A monocentric retrospective study2
Physical activity and sedentary behaviour in patients admitted with COPD: Associated factors2
Sarcoidosis Diagnostic Score (SDS) system: Impact of race, sex, organ involvement and duration of symptoms prior to diagnosis2
Association between persistent dyspnea and psychological distress in COVID-19 survivors. A cross-sectional evaluation at 11 months after hospitalization2
Increasing sleep apnoea burden in the elderly in Finland from 1996 to 2018: A national registry study2
Real-world management of unresectable stage III non-small-cell lung cancer: Impact of durvalumab consolidation therapy in French clinical practice2
Fast pleurodesis combining talc poudrage and indwelling pleural catheter for the management of recurrent malignant pleural effusions2
Acute hemodynamic response to inhaled treprostinil in pulmonary hypertension associated with interstitial lung disease: a case highlighting unresolved questions2
Titanium dental implants-related acute pneumonitis2
Effect of elexacaftor-tezacaftor-ivacaftor on lipid parameters in adults with cystic fibrosis: A single centre preliminary report2
Cardiac MRI and the “lung phenotype” in pulmonary hypertension: Overlap with group 3 or distinct entity?2
Behaviour change interventions for physical activity in adults with chronic obstructive pulmonary disease; A systematic review and meta-analysis2
Characteristics of lung nodules detected by low-dose CT scan: Results from the French lung cancer screening study DEP KP-802
Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?2
Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting2
PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitors2
The impact of deep venous thrombosis on 90 day mortality in chronic obstructive pulmonary disease patients presenting with pulmonary embolism2
Chalazion and hordeolum associated with Elexacaftor-Tezacaftor-Ivacaftor use in children with cystic fibrosis2
Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French national study2
Effectiveness of a home-based pulmonary rehabilitation programme in people recovering from a severe and critically COVID-19 infection2
Efficacy of bronchial thermoplasty in patients with severe asthma and frequent severe exacerbations: A randomized controlled study✰2
Dupilumab-induced rhinitis in severe asthma patients: A case series2
Diffuse infiltrative lymphocytic syndrome in recently diagnosed HIV patient: a case-report DILS-ILD responsive to steroids2
The incidence of pleural infections in Finland2
Radiologist-reported tension features on x-ray are not associated with physiological instability in ED patients with primary spontaneous pneumothorax2
Addressing the inequities in interstitial lung disease care outside specialised centres in Australia2
Outcomes of cannabis smoking in patients with lung cancer: findings from KBP-CPHG-20202
Corrigendum to “Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa” [Respiratory Medicine and Research 86 (2024) 101133]2
1.611300945282